Analysis of endogenous PrPC processing in neuronal and non-neuronal cell lines

Methods in Molecular Biology

Volumn 459, Issue , 2008, Pages 229-239

  Lewis, Victoria ^a   Collins, Steven J ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Endogenous cleavage; Endoproteolytic processing; Prion protein (PrP); PrP C; PrPres

Indexed keywords

EID: 84934436876     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-59745-234-2_15     Document Type: Article

References (19)

1. Bendheim PE, Brown HR, Rudelli RD, et al. (1992) Nearly ubiquitous tissue distribution of the scrapie agent precursor protein. Neurology; 42(1): 149-156.
2. Horiuchi M, Yamazaki N, Ikeda T, Ishiguro N, Shinagawa M. (1995) A cellular form of prion protein (PrPC) exists in many non-neuronal tissues of sheep. J Gen Virol; 76(10): 2583-2587.
3. Ford MJ, Burton LJ, Morris RJ, Hall SM. (2002) Selective expression of prion protein in peripheral tissues of the adult mouse. Neuroscience; 113(1): 177-192.
4. Sakaguchi S, Katamine S, Shigematsu K, et al. (1995) Accumulation of proteinase K-resistant prion protein (PrP) is restricted by the expression level of normal PrP in mice inoculated with a mouse-adapted strain of the Creutzfeldt-Jakob disease agent. J Virol; 69(12): 7586-7592.
5. Bueler H, Aguzzi A, Sailer A, et al. (1993) Mice devoid of PrP are resistant to scrapie. Cell; 73(7): 1339-1347.
6. Collins SJ, Lawson VA, Masters CL. (2004) Transmissible spongiform encephalopathies. Lancet; 363(9402): 51-61.
7. Lawson VA, Collins SJ, Masters CL, Hill AF. (2005) Prion protein glycosylation. J Neurochem; 93(4): 793-801.
8. Ehlers MR, Riordan JF. (1991) Membrane proteins with soluble counterparts: role of proteolysis in the release of transmembrane proteins. Biochemistry; 30(42): 10065-10074.
9. Chen SG, Teplow DB, Parchi P, Teller JK, Gambetti P, Autilio-Gambetti L. (1995) Truncated forms of the human prion protein in normal brain and in prion diseases. J Biol Chem; 270(32): 19173-19180.
10. Jimenez-Huete A, Lievens PM, Vidal R, et al. (1998) Endogenous proteolytic cleavage of normal and disease-associated isoforms of the human prion protein in neural and non-neural tissues. Am J Pathol; 153(5): 1561-1572.
11. Yadavalli R, Guttmann RP, Seward T, Centers AP, Williamson RA, Telling GC. (2004) Calpain-dependent endoproteolytic cleavage of PrPSc modulates scrapie prion propagation. J Biol Chem; 279(21): 21948-21956.
12. Vincent B, Paitel E, Saftig P, et al. (2001) The disintegrins ADAM10 and TACE contribute to the constitutive and phorbol ester-regulated normal cleavage of the cellular prion protein. J Biol Chem; 276(41): 37743-37746.
13. McMahon HE, Mange A, Nishida N, Creminon C, Casanova D, Lehmann S. (2001) Cleavage of the amino terminus of the prion protein by reactive oxygen species. J Biol Chem; 276(3): 2286-2291.
14. Watt NT, Taylor DR, Gillott A, Thomas DA, Perera WS, Hooper NM. (2005) Reactive oxygen species-mediated beta-cleavage of the prion protein in the cellular response to oxidative stress. J Biol Chem; 280(43): 35914-35921.
15. Wilquet V, De Strooper B. (2004) Amyloid-beta precursor protein processing in neurodegeneration. Curr Opin Neurobiol; 14(5): 582-588.
16. Buxbaum JD, Liu KN, Luo Y, et al. (1998) Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated alpha-secretase cleavage of the Alzheimer amyloid protein precursor. J Biol Chem; 273(43): 27765-27767.
17. Forloni G, Angeretti N, Chiesa R, et al. (1993) Neurotoxicity of a prion protein fragment. Nature; 362(6420): 543-546.
18. Checler F, Vincent B. (2002) Alzheimer's and prion diseases: distinct pathologies, common proteolytic denominators. Trends Neurosci; 25(12): 616-620.
19. Vincent B. (2004) ADAM proteases: protective role in Alzheimer's and prion diseases? Curr Alzheimer Res; 1(3): 165-174.